WCM INVESTMENT MANAGEMENT, LLC has opened a new $828.7M position in $CAH, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 12-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $CAH.
$CAH Hedge Fund Activity
We have seen 632 institutional investors add shares of $CAH stock to their portfolio, and 578 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WCM INVESTMENT MANAGEMENT, LLC added 4,032,682 shares (+inf%) to their portfolio in Q4 2025, for an estimated $828,716,151
- WELLINGTON MANAGEMENT GROUP LLP added 3,511,579 shares (+153.2%) to their portfolio in Q3 2025, for an estimated $551,177,439
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,449,400 shares (+94.9%) to their portfolio in Q3 2025, for an estimated $384,457,824
- MARSHALL WACE, LLP removed 1,864,356 shares (-96.6%) from their portfolio in Q3 2025, for an estimated $292,629,317
- HOLOCENE ADVISORS, LP added 1,128,358 shares (+141.4%) to their portfolio in Q3 2025, for an estimated $177,107,071
- BLACKROCK, INC. added 916,791 shares (+3.0%) to their portfolio in Q3 2025, for an estimated $143,899,515
- FMR LLC removed 854,880 shares (-13.6%) from their portfolio in Q3 2025, for an estimated $134,181,964
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CAH Insider Trading Activity
$CAH insiders have traded $CAH stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $CAH stock by insiders over the last 6 months:
- JASON M. HOLLAR (Chief Executive Officer) has made 0 purchases and 5 sales selling 143,606 shares for an estimated $21,424,215.
- AARON E ALT (Chief Financial Officer) has made 0 purchases and 2 sales selling 48,243 shares for an estimated $7,177,389.
- STEPHEN M MASON (CEO, GMPD Segment) has made 0 purchases and 3 sales selling 41,575 shares for an estimated $6,187,063.
- JESSICA L MAYER (Chief Legal/Compliance Officer) has made 0 purchases and 3 sales selling 38,078 shares for an estimated $5,666,832.
- OLA M SNOW (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 28,151 shares for an estimated $4,192,916.
- DEBORAH WEITZMAN (CEO, PSS Segment) sold 21,367 shares for an estimated $3,216,374
- MICHELLE D. GREENE (Chief Information Officer) has made 0 purchases and 2 sales selling 13,500 shares for an estimated $2,009,043.
- MARY C. SCHERER (Chief Accounting Officer) sold 6,766 shares for an estimated $1,009,825
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CAH Government Contracts
We have seen $231,591,639 of award payments to $CAH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF APRIL 2025.: $10,194,510
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF JANUARY 2025: $9,899,536
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF MARCH 2025: $9,596,571
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF FEBRUARY 2025: $8,571,978
- EXPRESS REPORT: MSPV EXPENDITURES FOR MAY 2025: $4,117,385
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$CAH Congressional Stock Trading
Members of Congress have traded $CAH stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CAH stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CAH Analyst Ratings
Wall Street analysts have issued reports on $CAH in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 01/29/2026
- Mizuho issued a "Outperform" rating on 11/04/2025
- TD Cowen issued a "Buy" rating on 11/03/2025
- UBS issued a "Buy" rating on 10/31/2025
To track analyst ratings and price targets for $CAH, check out Quiver Quantitative's $CAH forecast page.
$CAH Price Targets
Multiple analysts have issued price targets for $CAH recently. We have seen 8 analysts offer price targets for $CAH in the last 6 months, with a median target of $236.0.
Here are some recent targets:
- Steven Valiquette from Mizuho set a target price of $235.0 on 02/06/2026
- Erin Wright from Morgan Stanley set a target price of $245.0 on 01/29/2026
- Stephen Baxter from Wells Fargo set a target price of $237.0 on 01/15/2026
- Daniel Grosslight from Citigroup set a target price of $244.0 on 01/09/2026
- Glen Santangelo from Barclays set a target price of $243.0 on 12/09/2025
- Charles Rhyee from TD Cowen set a target price of $225.0 on 11/03/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $220.0 on 10/31/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $CAH ticker page for more data.
